Q96C36 (P5CR2_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 98.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Pyrroline-5-carboxylate reductase 2 Short name=P5C reductase 2 Short name=P5CR 2 EC=1.5.1.2 | ||
| Gene names |
| ||
| Organism | Homo sapiens (Human) [Reference proteome] | ||
| Taxonomic identifier | 9606 [NCBI] | ||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 320 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Housekeeping enzyme that catalyzes the last step in proline biosynthesis. In some cell types, such as erythrocytes, its primary function may be the generation of NADP+. Can utilize both NAD and NADP. Has higher affinity for NADP, but higher catalytic efficiency with NADH. Ref.7 Ref.8 |
| Catalytic activity | L-proline + NAD(P)+ = 1-pyrroline-5-carboxylate + NAD(P)H. Ref.7 Ref.8 |
| Enzyme regulation | Subject to competitive inhibition by NADP. Not inhibited by proline. Ref.7 Ref.8 |
| Pathway | Amino-acid biosynthesis; L-proline biosynthesis; L-proline from L-glutamate 5-semialdehyde: step 1/1. |
| Subunit structure | Homodecamer; composed of 5 homodimers Probable. Ref.8 |
| Subcellular location | |
| Tissue specificity | |
| Sequence similarities | Belongs to the pyrroline-5-carboxylate reductase family. |
| Biophysicochemical properties | Kinetic parameters: KM=0.64 mM for NADH Ref.8 KM=0.04 mM for NADPH KM=1.49 mM for pyrroline-5-carboxylate (in the presence of NADH) KM=0.23 mM for pyrroline-5-carboxylate (in the presence of NADPH) Vmax=28.5 µmol/min/µg enzyme (in the presence of NADH) Vmax=3.7 µmol/min/µg enzyme (in the presence of NADPH) |
Ontologies
| Keywords | |
|---|---|
| Biological process | Amino-acid biosynthesis Proline biosynthesis |
| Cellular component | Cytoplasm |
| Ligand | NADP |
| Molecular function | Oxidoreductase |
| PTM | Acetylation Phosphoprotein |
| Technical term | Complete proteome Direct protein sequencing Reference proteome |
| Gene Ontology (GO) | |
| Biological_process | L-proline biosynthetic process Inferred from electronic annotation. Source: UniProtKB-UniPathway |
| Cellular_component | cytoplasm Inferred from electronic annotation. Source: UniProtKB-SubCell |
| Molecular_function | nucleotide binding Inferred from electronic annotation. Source: InterPro pyrroline-5-carboxylate reductase activityInferred from electronic annotation. Source: EC |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Initiator methionine | 1 | 1 | Removed Ref.6 | ||||||
| Chain | 2 – 320 | 319 | Pyrroline-5-carboxylate reductase 2 | PRO_0000187317 | |||||
Regions | |||||||||
| Nucleotide binding | 6 – 11 | 6 | NADP By similarity | ||||||
| Nucleotide binding | 69 – 72 | 4 | NADP By similarity | ||||||
| Nucleotide binding | 95 – 97 | 3 | NADP By similarity | ||||||
Sites | |||||||||
| Binding site | 34 | 1 | NADP; via carbonyl oxygen By similarity | ||||||
| Binding site | 56 | 1 | NADP By similarity | ||||||
Amino acid modifications | |||||||||
| Modified residue | 2 | 1 | N-acetylserine Ref.6 | ||||||
| Modified residue | 304 | 1 | Phosphoserine Ref.10 Ref.11 Ref.13 | ||||||
Experimental info | |||||||||
| Sequence conflict | 13 | 1 | Y → N in AAP97169. Ref.1 | ||||||
| Sequence conflict | 23 – 24 | 2 | GI → AF in AAP97169. Ref.1 | ||||||
| Sequence conflict | 72 – 73 | 2 | PH → HI in AAP97169. Ref.1 | ||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Cloning of a new human cDNA homologous to human pyrroline 5-carboxylate reductase mRNA." Yue P., Yu L., Zhao S.Y. Submitted (AUG-1998) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [2] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. |
| [3] | "The DNA sequence and biological annotation of human chromosome 1." Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K. Bentley D.R.Nature 441:315-321(2006) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [4] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Cervix and Skin. |
| [6] | Bienvenut W.V., Heiserich L., Gottlieb E., Zebisch A., Kolch W. Submitted (OCT-2008) to UniProtKB Cited for: PROTEIN SEQUENCE OF 2-17, CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT SER-2, MASS SPECTROMETRY. Tissue: Colon carcinoma. |
| [7] | "Pyrroline-5-carboxylate reductase in human erythrocytes." Yeh G.C., Harris S.C., Phang J.M. J. Clin. Invest. 67:1042-1046(1981) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, CATALYTIC ACTIVITY, ENZYME REGULATION, TISSUE SPECIFICITY. |
| [8] | "Purified human erythrocyte pyrroline-5-carboxylate reductase. Preferential oxidation of NADPH." Merrill M.J., Yeh G.C., Phang J.M. J. Biol. Chem. 264:9352-9358(1989) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, CATALYTIC ACTIVITY, SUBUNIT, SUBCELLULAR LOCATION, ENZYME REGULATION, BIOPHYSICOCHEMICAL PROPERTIES, TISSUE SPECIFICITY. |
| [9] | "A probability-based approach for high-throughput protein phosphorylation analysis and site localization." Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P. Nat. Biotechnol. 24:1285-1292(2006) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Cervix carcinoma. |
| [10] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-304, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [11] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-304, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [12] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [13] | "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation." Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B. Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-304, MASS SPECTROMETRY. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AF087859 mRNA. Translation: AAP97169.1. AK291913 mRNA. Translation: BAF84602.1. AL117348 Genomic DNA. Translation: CAI21802.1. CH471098 Genomic DNA. Translation: EAW69762.1. BC014868 mRNA. Translation: AAH14868.1. BC020553 mRNA. Translation: AAH20553.1. |
| IPI | IPI00470610. |
| RefSeq | NP_001258610.1. NM_001271681.1. NP_037460.2. NM_013328.3. |
| UniGene | Hs.654718. |
3D structure databases | |
| ProteinModelPortal | Q96C36. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | Q96C36. 3 interactions. |
| MINT | MINT-1150827. |
| STRING | 9606.ENSP00000342502. |
PTM databases | |
| PhosphoSite | Q96C36. |
Polymorphism databases | |
| DMDM | 60390642. |
Proteomic databases | |
| PaxDb | Q96C36. |
| PRIDE | Q96C36. |
Protocols and materials databases | |
| DNASU | 29920. |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000343818; ENSP00000342502; ENSG00000143811. |
| GeneID | 29920. |
| KEGG | hsa:29920. |
| UCSC | uc001hpq.3. human. |
Organism-specific databases | |
| CTD | 29920. |
| GeneCards | GC01M226107. |
| H-InvDB | HIX0200217. |
| HGNC | HGNC:30262. PYCR2. |
| HPA | HPA056873. |
| neXtProt | NX_Q96C36. |
| PharmGKB | PA134881955. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | COG0345. |
| HOGENOM | HOG000230247. |
| HOVERGEN | HBG053399. |
| InParanoid | Q96C36. |
| KO | K00286. |
| OMA | EQNAFRH. |
Enzyme and pathway databases | |
| UniPathway | UPA00098; UER00361. |
Gene expression databases | |
| ArrayExpress | Q96C36. |
| Bgee | Q96C36. |
| CleanEx | HS_PYCR2. |
| Genevestigator | Q96C36. |
| GermOnline | ENSG00000143811. Homo sapiens. |
Family and domain databases | |
| Gene3D | 3.40.50.720. 1 hit. |
| InterPro | IPR008927. 6-PGluconate_DH_C-like. IPR016040. NAD(P)-bd_dom. IPR004455. NADP_OxRdtase_F420. IPR000304. Pyrroline-COOH_reductase. [Graphical view] |
| PANTHER | PTHR11645. PTHR11645. 1 hit. |
| Pfam | PF03807. F420_oxidored. 1 hit. [Graphical view] |
| PIRSF | PIRSF000193. Pyrrol-5-carb_rd. 1 hit. |
| SUPFAM | SSF48179. 6DGDH_C_like. 1 hit. |
| TIGRFAMs | TIGR00112. proC. 1 hit. |
| PROSITE | PS00521. P5CR. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| DrugBank | DB00172. L-Proline. DB00157. NADH. |
| GenomeRNAi | 29920. |
| NextBio | 52520. |
Entry information
| Entry name | P5CR2_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q96C36 Secondary accession number(s): A8K798, Q7Z515, Q9Y5J4 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 1 Human chromosome 1: entries, gene names and cross-references to MIM |
| PATHWAY comments Index of metabolic and biosynthesis pathways |
| SIMILARITY comments Index of protein domains and families |

Clusters with
